SOLS
HON
CCK
DD

Lee Rose

Known title: DirectorCIK: 0001681150

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

Solstice Settles Lawsuit; Mizuho Cuts Target to $65. Solstice Advanced Materials announced a settlement with plaintiffs, stating it does not expect a material impact on business operations or financial performance. In related analyst activity, Mizuho lowered its price target to $65 while maintaining a Neutral rating, whereas RBC Capital reiterated an Outperform rating with an $82 target. The company is also scheduled to report third-quarter results on November 4, 2026.

this person other insiders at SOLS

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Honeywell Q3 Earnings Expected to Decline. Honeywell’s upcoming third‑quarter earnings are projected to fall short of previous results. Analysts point out that the company’s long‑term outlook still looks appealing. A recent comparison article suggests Honeywell may be a stronger choice than Corning for 2026.

this person other insiders at HON

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

UBS Cuts Crown Holdings Price Target to $116. UBS has lowered its price target for Crown Holdings to $116 while maintaining a Neutral rating. This new target is below the current support level of $118.66, suggesting potential downside pressure. The move stands out as the new target is significantly lower than the average analyst estimate of $136.57.

this person other insiders at CCK

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

DuPont receives analyst upgrades and announces quarterly dividend. DuPont de Nemours was highlighted in several recent analyst reports. RBC Capital kept an Outperform rating while lowering its price target to $160, and Barclays began coverage with an Overweight rating and a $156 target. The company also announced its regular quarterly dividend for common stock. These developments show ongoing analyst attention and a focus on returning cash to shareholders.

this person other insiders at DD

Transaction History

SOLS▲ Buy—
SOLS▲ Buy—
HON▲ Buy$130K
HON▲ Buy$66K
HON▲ Buy$69K
HON▲ Buy$17K
CCK▲ Buy$40K
CCK▲ Buy$36K
DD▼ Sell$986K
DD▲ Buy$706K
DD▼ Sell$982K
DD▲ Buy$877K

We use analytics to understand how market-wall is used. No personal data is sold.